Abstract
Primary adenocarcinoma of the esophagus, previously considered a rare neoplasm, has shown a dramatic increase in its incidence rate among White men in the United States since 1970. The reason for this increase is unknown. Since the presence of Barrett's esophagus is essential for the development of most esophageal adenocarcinomas, the increasing incidence of esophageal adenocarcinoma may be related to an increasing prevalence of Barrett's esophagus, and its precursor, gastroesophageal reflux. An association between this increasing incidence and an increasing use of pharmaceutical agents that relax the lower esophageal sphincter is proposed. The data on the dollar amount and approximate quantity in milligrams purchasedper capita through retail pharmacies and hospitals in the United States from 1957 to 1986 are presented for four categories of such agents. An upward trend is observed for all four categories.Cancer Causes and Control 1994,5, 573–578.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yang PC, Davis S. Incidence of cancer of the esophagus in the US by histologic type.Cancer 1988;61: 612–7.
Hesketh PJ, Clapp RW, Doos WG, Spechler SJ. The increasing frequency of adenocarcinoma of the esophagus.Cancer 1989;64: 526–30.
Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia.JAMA 1991;265: 1287–9.
Zheng T, Mayne ST, Holford TR,et al. Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935–89.Cancer Causes Control 1993;3: 481–92.
Blot WJ, Devesa SS, Fraumeni JF Jr. continuing climb in rates of esophageal adenocarcinoma: an update.JAMA 1993;270: 1320.
Moeller H, Jensen OM. Trends in incidence of oesophagus, cardia, and stomach cancer in Denmark, 1943–1982. Presented at the Sixth Annual ECP Symposium, International Symposium on Gastric Carcinogenesis; March 1988; London, UK.
Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites.Br J Cancer 1990;59: 440–3.
Spechler SJ, Goyal RK. Barrett's esophagus.N Engl J Med 1986;315: 362–71.
Sjogren RW, Johnson LF. Barrett's esophagus: a review.Am J Med 1983;74: 313–21.
Sarr MG, Hamilton SR, Marrone GC, Cameron JL. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.Am J Surg 1985;149: 187–93.
Thompson JJ, Zinsser KR, Enterline HT. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction.Hum Pathol 1983;14: 42–61.
Phillips RW, Wong RKH. Barrett's esophagus. Natural history, incidence, etiology, and complications.Gastroenterol Clin North Am 1991;20: 791–816.
Castell DO. The lower esophageal sphincter. Physiologic and clinical aspects.Ann Intern Med 1975;83: 390–401.
Spechler SJ, and the Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans.N Engl J Med 1992;326: 786–92.
Sittig M.Pharmaceutical Manufacturing Encyclopedia.2nd Ed. Park Ridge, NJ (USA): Noyes, 1988.
Department of Economic and Social Development, Statistical Division.1970, 1980, and 1990 Demographic Yearbook, Twenty-second, Thirty-second, and Forty-second Issue. New York, NY (USA): United Nations, 1971, 1981, 1991.
Drug Topics Red Book. Published annually by Topics Publishing Co., Inc., New York (USA), 1957–72; then by Medical Economics Data, Inc., New Jersey (USA), 1973–86.
Day NE, Muñoz N. Esophagus. In: Schottenfeld D, Fraumeni JF Jr, eds.Cancer Epidemiology and Prevention. Philadelphia, PA (USA): WB Saunders, 1982: 596–623.
Levi F, Ollyo JB, La Vecchia C, Boyle P, Monnier P, Savary M. The consumption of tobacco, alcohol and the risk of adenocarcinoma in Barrett's oesophagus.Int J Cancer 1990;45: 852–4.
Gray JR, Coldman AJ, MacDonald WC. Cigarette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagus.Cancer 1992;69: 2227–31.
Menke-Pluymers MBF, Hop WCJ, Dees J, van Blankenstein M, Tilanus HW, the Rotterdam Esophageal Tumor Study Group. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus.Cancer 1993;72: 1155–8.
Gray MR, Donnelly RJ, Kingsnorth AN. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar-lined esophagus.Gut 1993;34: 727–31.
Kabar GC, Ng SKC, Wynder EL. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia.Cancer Causes Control 1993;4: 123–32.
Wynder EL, Hoffmann D. Tobacco and health. A societal challenge.N Engl J Med 1979;300: 894–903.
Stephen AM, Wald NJ. Trend in individual consumption of dietary fat in the United States, 1920–1984.Am J Clin Nutr 1990;52: 457–69.
Slattery ML, Randall DE. Trends in coronary heart disease mortality and food consumption in the United States between 1909 and 1980.Am J Clin Nutr 1988;47: 1060–7.
LaCroix AZ, Mead LA, Liang K, Thomas CB, Pearson TA. Coffee consumption and the incidence of coronary heart disease.N Engl J Med 1986;315: 977–82.
Gilman AG, Rall TW, Nies AS, Taylor P, eds.Goodman and Gilman's The Pharmacological Basis of Therapeutics.8th Edition. New York, NY (USA): Pergamon Press, 1990.
Author information
Authors and Affiliations
Additional information
This project is funded, in part, by grants from the Milton Fund of the Harvard Medical School and from the Beth Israel Hospital Pathology Foundation.
Rights and permissions
About this article
Cite this article
Wang, H.H., Hsieh, Cc. & Antonioli, D.A. Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States). Cancer Causes Control 5, 573–578 (1994). https://doi.org/10.1007/BF01831386
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01831386